Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Diana H. Ferreira, Slavica Kochovska, Vanessa N. Brunelli & David C. Currow. (2023) Understanding persistent breathlessness: impact on patients and optimal approaches to symptomatic reduction – an overview. Expert Review of Respiratory Medicine 17:5, pages 365-379.
Read now
Read now
Diana H Ferreira, Slavica Kochovska, Richard McNeill & David C Currow. (2023) Current pharmacological strategies for symptomatic reduction of persistent breathlessness – a literature review. Expert Opinion on Pharmacotherapy 24:2, pages 233-244.
Read now
Read now
Jesús Recio Iglesias, Jesús Díez-Manglano, Francisco López García, José Antonio Díaz Peromingo, Pere Almagro & José Manuel Varela Aguilar. (2020) Management of the COPD Patient with Comorbidities: An Experts Recommendation Document. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1015-1037.
Read now
Read now
Zafar A Usmani, Kristin V Carson-Chahhoud, Adrian J Esterman & Brian J Smith. (2018) A randomized placebo-controlled trial of paroxetine for the management of anxiety in chronic obstructive pulmonary disease (PAC Study). Journal of Multidisciplinary Healthcare 11, pages 287-293.
Read now
Read now
Carlo Barbetta, David C. Currow & Miriam J. Johnson. (2017) Non-opioid medications for the relief of chronic breathlessness: current evidence. Expert Review of Respiratory Medicine 11:4, pages 333-341.
Read now
Read now
Athanasios Tselebis, Argyro Pachi, Ioannis Ilias, Epaminondas Kosmas, Dionisios Bratis, Georgios Moussas & Nikolaos Tzanakis. (2016) Strategies to improve anxiety and depression in patients with COPD: a mental health perspective. Neuropsychiatric Disease and Treatment 12, pages 297-328.
Read now
Read now
Thierry Perez, Pierre Régis Burgel, Jean-Louis Paillasseur, Denis Caillaud, Gaetan Deslée, Pascal Chanez & Nicolas Roche. (2015) Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1663-1672.
Read now
Read now
Bravein Amalakuhan & Sandra G Adams. (2015) Improving outcomes in chronic obstructive pulmonary disease: the role of the interprofessional approach. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1225-1232.
Read now
Read now
Christine Garvey. (2012) Depression in Patients with Chronic Obstructive Pulmonary Disease. Postgraduate Medicine 124:3, pages 101-109.
Read now
Read now
Abebaw Mengistu Yohannes & Martin Joseph Connolly. (2011) Do antidepressants work in patients with chronic obstructive pulmonary disease with comorbid depression?. Expert Review of Respiratory Medicine 5:6, pages 727-729.
Read now
Read now
David A Sonetti, Angela C Hospenthal & Sandra G Adams. (2010) Integrated management strategies for chronic obstructive pulmonary disease. Journal of Multidisciplinary Healthcare 3, pages 181-188.
Read now
Read now
Abebaw Mengistu Yohannes. (2008) Management of anxiety and depression in patients with COPD. Expert Review of Respiratory Medicine 2:3, pages 337-347.
Read now
Read now
Anna Spathis & Sara Booth. (2008) End of life care in chronic obstructive pulmonary disease: in search of a good death. International Journal of Chronic Obstructive Pulmonary Disease 3:1, pages 11-29.
Read now
Read now
David B. Coultas, Drew W. Edwards, Bethany Barnett & Peter Wludyka. (2007) Predictors of Depressive Symptoms in Patients with COPD and Health Impact. COPD: Journal of Chronic Obstructive Pulmonary Disease 4:1, pages 23-28.
Read now
Read now
Frederick S. Wamboldt. (2005) Anxiety and Depression in COPD: A Call (and Need) for Further Research. COPD: Journal of Chronic Obstructive Pulmonary Disease 2:2, pages 199-201.
Read now
Read now
Articles from other publishers (59)
Giacomo Gatti, Mario Giordano & Corrado Mollica. 2023. Noninvasive Mechanical Ventilation and Neuropsychiatric Disorders. Noninvasive Mechanical Ventilation and Neuropsychiatric Disorders
145
160
.
Joon Young Choi, Jin Woo Song & Chin Kook Rhee. (2022) Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease. Tuberculosis and Respiratory Diseases 85:2, pages 122-136.
Crossref
Crossref
Su Won Lee, Jae Jun Park, Yee Ran Lyu, Eun Jung Lee, Si Yeon Kim, Weechang Kang, Ji Woong Son, In Chul Jung & Yang Chun Park. (2022) The effect of lung-conduction exercise in chronic obstructive pulmonary disease. Medicine 101:3, pages e28629.
Crossref
Crossref
Claire Kyung Sun Meikle, Justin Fortune Creeden, Cheryl McCullumsmith & Randall G. Worth. (2021) SSRIs: Applications in inflammatory lung disease and implications for COVID‐19. Neuropsychopharmacology Reports 41:3, pages 325-335.
Crossref
Crossref
David Hui, Kari Bohlke, Ting Bao, Toby C. Campbell, Patrick J. Coyne, David C. Currow, Arjun Gupta, Aliza L. Leiser, Masanori Mori, Stefano Nava, Lynn F. Reinke, Eric J. Roeland, Carole Seigel, Declan Walsh & Margaret L. Campbell. (2021) Management of Dyspnea in Advanced Cancer: ASCO Guideline. Journal of Clinical Oncology 39:12, pages 1389-1411.
Crossref
Crossref
G. Peiffer, M. Underner, J. Perriot & G. Fond. (2021) BPCO, troubles anxio-dépressifs et cognitifs : l’inflammation joue-t-elle un rôle prépondérant ?. Revue des Maladies Respiratoires 38:4, pages 357-371.
Crossref
Crossref
David Hui, Matthew Maddocks, Miriam J. Johnson, Magnus Ekström, Steffen T. Simon, Anna C. Ogliari, Sara Booth & Carla I. Ripamonti. (2020) Management of breathlessness in patients with cancer: ESMO Clinical Practice Guidelines. ESMO Open 5:6, pages e001038.
Crossref
Crossref
Su Won Lee, Yee Ran Lyu, So Jung Park, Jin Young Kwak, Won Kyung Yang, Seung Hyung Kim, Weechang Kang, Ji Woong Son, In Chul Jung & Yang Chun Park. (2020) The effect of lung-conduction exercise in chronic obstructive pulmonary disease. Medicine 99:18, pages e19826.
Crossref
Crossref
Aziz A. Ansari, Daniel H. Pomerantz, Robert L. Jayes, Eric A. Aguirre & Rachel D. Havyer. (2018) Promoting Primary Palliative Care in Severe Chronic Obstructive Pulmonary Disease: Symptom Management and Preparedness Planning. Journal of Palliative Care 34:2, pages 85-91.
Crossref
Crossref
David C. Currow, Magnus Ekström, Sandra Louw, Julie Hill, Belinda Fazekas, Katherine Clark, Patricia M. Davidson, Christine McDonald, Dimitar Sajkov, Nikki McCaffrey, Matthew Doogue, Amy P. Abernethy & Meera Agar. (2019) Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial. European Respiratory Journal 53:1, pages 1801270.
Crossref
Crossref
Charlotte E. Pelgrim, Julia D. Peterson, Harry R. Gosker, Annemie M.W.J. Schols, Ardy van Helvoort, Johan Garssen, Gert Folkerts & Aletta D. Kraneveld. (2019) Psychological co-morbidities in COPD: Targeting systemic inflammation, a benefit for both?. European Journal of Pharmacology 842, pages 99-110.
Crossref
Crossref
Karin F. Hoth & Elizabeth Kozora. 2019. Handbook on the Neuropsychology of Aging and Dementia. Handbook on the Neuropsychology of Aging and Dementia
661
674
.
Justyna Pollok, Joep EM van Agteren & Kristin V Carson-Chahhoud. (2018) Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2018:12.
Crossref
Crossref
Nicholas T. Vozoris, Peter C. Austin & Paula A. Rochon. (2018) Statistical compared to clinical significance and the risk of misattribution. European Respiratory Journal 52:5, pages 1801868.
Crossref
Crossref
Nicholas T. Vozoris, Xuesong Wang, Peter C. Austin, Anne L. Stephenson, Denis E. O'Donnell, Andrea S. Gershon, Sudeep S. Gill & Paula A. Rochon. (2018) Serotonergic antidepressant use and morbidity and mortality among older adults with COPD. European Respiratory Journal 52:1, pages 1800475.
Crossref
Crossref
Pouria Kashkouli & Kimberly Ann Hardin. (2017) Palliative Care and Rehabilitation in Hospitalized Patients with Respiratory Failure. Hospital Medicine Clinics 6:4, pages 562-578.
Crossref
Crossref
Abebaw Mengistu Yohannes & Iracema Leroi. 2017. Depression and Anxiety in Patients with Chronic Respiratory Diseases. Depression and Anxiety in Patients with Chronic Respiratory Diseases
167
182
.
Syeda Shaherbano Naqvi, Justyna Pollok, Joseph EM van Agteren, Zafar A Usmani, Kristin V Carson, Brian J Smith & Julio Licinio. (2016) Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Miriam J. Johnson, Carlo Barbetta, David C. Currow, Matthew Maddocks, Vanessa McDonald, Ravi Mahadeva & Martina Mason. 2016. Palliative Care in Respiratory Disease. Palliative Care in Respiratory Disease
153
171
.
Carlos Martinez Rivera, Joaquín Costan Galicia, Bernardino Alcázar Navarrete, Cayo Garcia-Polo, Luis Alberto Ruiz Iturriaga, Alberto Herrejón, Jose Antonio Ros Lucas, Patricia García-Sidro, Gema Tirado-Conde, Jose Luis López-Campos, Sagrario Mayoralas Alises, Javier de Miguel-Díez, Cristina Esquinas & Marc Miravitlles. (2016) Factors Associated with Depression in COPD: A Multicenter Study. Lung 194:3, pages 335-343.
Crossref
Crossref
María Victoria González-Gutiérrez, José Guerrero Velázquez, Concepción Morales García, Francisco Casas Maldonado, Francisco Javier Gómez Jiménez & Francisco González Vargas. (2016) Modelo predictivo de ansiedad y depresión en pacientes españoles con enfermedad pulmonar obstructiva crónica estable. Archivos de Bronconeumología 52:3, pages 151-157.
Crossref
Crossref
María Victoria González-Gutiérrez, José Guerrero Velázquez, Concepción Morales García, Francisco Casas Maldonado, Francisco Javier Gómez Jiménez & Francisco González Vargas. (2016) Predictive Model for Anxiety and Depression in Spanish Patients With Stable Chronic Obstructive Pulmonary Disease. Archivos de Bronconeumología (English Edition) 52:3, pages 151-157.
Crossref
Crossref
Laura-Jane Smith & Jennifer K. Quint. 2015. Controversies in COPD. Controversies in COPD
297
322
.
Sarah Awan & Andrew Wilcock. (2015) Nonopioid medication for the relief of refractory breathlessness. Current Opinion in Supportive & Palliative Care 9:3, pages 227-231.
Crossref
Crossref
M. Kloke & N. Cherny. (2015) Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines. Annals of Oncology 26, pages v169-v173.
Crossref
Crossref
. (2014) Consider behavioural strategies in addition to antidepressants in clinically depressed patients with chronic obstructive pulmonary disease. Drugs & Therapy Perspectives 31:2, pages 52-56.
Crossref
Crossref
Osama M. Momtaz, Salwa M. Rabei, Nezar R. Tawfike & Ali A. Hasan. (2015) Effect of treatment of depression and anxiety on physiological state of severe COPD patients. Egyptian Journal of Chest Diseases and Tuberculosis 64:1, pages 29-34.
Crossref
Crossref
A. M. Yohannes & G. S. Alexopoulos. (2014) Pharmacological Treatment of Depression in Older Patients with Chronic Obstructive Pulmonary Disease: Impact on the Course of the Disease and Health Outcomes. Drugs & Aging 31:7, pages 483-492.
Crossref
Crossref
Vincent S. Fan & Paula M. Meek. (2014) Anxiety, Depression, and Cognitive Impairment in Patients with Chronic Respiratory Disease. Clinics in Chest Medicine 35:2, pages 399-409.
Crossref
Crossref
Athanasios Tselebis, Dionisios Bratis, Argiro Pachi, Georgios Moussas, Ioannis Ilias, Maria Harikiopoulou, Elpida Theodorakopoulou, Silvia Dumitru, Epaminondas Kosmas, Alexandros Vgontzas, Nikolaos Siafakas & Nikolaos Tzanakis. (2013) A pulmonary rehabilitation program reduces levels of anxiety and depression inCOPD patients. Multidisciplinary Respiratory Medicine 8:1.
Crossref
Crossref
Jingjing Qian, Linda Simoni-Wastila, Gail B. Rattinger, Susan Lehmann, Patricia Langenberg, Ilene H. Zuckerman & Michael Terrin. (2013) Associations of depression diagnosis and antidepressant treatment with mortality among young and disabled Medicare beneficiaries with COPD. General Hospital Psychiatry 35:6, pages 612-618.
Crossref
Crossref
Jingjing Qian, Linda Simoni‐Wastila, Patricia Langenberg, Gail B. Rattinger, Ilene H. Zuckerman, Susan Lehmann & Michael Terrin. (2013) Effects of Depression Diagnosis and Antidepressant Treatment on Mortality in Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease. Journal of the American Geriatrics Society 61:5, pages 754-761.
Crossref
Crossref
Elizabeth Kozora & Karin F. Hoth. 2013. Handbook on the Neuropsychology of Aging and Dementia. Handbook on the Neuropsychology of Aging and Dementia
455
466
.
Rebecca T. Disler, David C. Currow, Jane L. Phillips, Tracy Smith, Miriam J. Johnson & Patricia M. Davidson. (2012) Interventions to support a palliative care approach in patients with chronic obstructive pulmonary disease: An integrative review. International Journal of Nursing Studies 49:11, pages 1443-1458.
Crossref
Crossref
PAUL A. CAFARELLA, TANJA W. EFFING, ZAFAR-AHMAD USMANI & PETER A. FRITH. (2012) Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: A literature review. Respirology 17:4, pages 627-638.
Crossref
Crossref
. (2012) Anexo 2 Preguntas respondidas por la UETS en la GPC para el tratamiento de pacientes con EPOC. Archivos de Bronconeumología 48, pages 61-80.
Crossref
Crossref
Vincent S. Fan & Nicholas D. Giardino. 2012. Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease
95
118
.
Zafar A Usmani, Kristin V Carson, Jien N Cheng, Adrian J Esterman & Brian J Smith. (2011) Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Anja Fritzsche, Annika Clamor & Andreas von Leupoldt. (2011) Effects of medical and psychological treatment of depression in patients with COPD – A review. Respiratory Medicine 105:10, pages 1422-1433.
Crossref
Crossref
DorAnne Donesky, Susan L. Janson, Huong Q. Nguyen, John Neuhaus, Torsten B. Neilands & Virginia Carrieri-Kohlman. (2011) Determinants of Frequency, Duration, and Continuity of Home Walking in Patients with COPD. Geriatric Nursing 32:3, pages 178-187.
Crossref
Crossref
David Taylor, Nicholas Meader, Victoria Bird, Steve Pilling, Francis Creed & David Goldberg. (2018) Pharmacological interventions for people with depression and
chronic physical health problems: systematic review and meta-analyses of
safety and efficacy. British Journal of Psychiatry 198:3, pages 179-188.
Crossref
Crossref
Fabrizio Boni, Andrea Corsonello & Domenico Panuccio. (2011) BPCO e depressione/ansia. Italian Journal of Medicine 5:1, pages 81-90.
Crossref
Crossref
H.-P. Kapfhammer. 2011. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
2511
2598
.
Susan McCrone & Heidi Putnam-Casdorph. 2011. Psychological Co-morbidities of Physical Illness. Psychological Co-morbidities of Physical Illness
415
453
.
S. Jouneau. (2010) D?pression et anxi?t? chez les patients atteints de BPCO. Revue des Maladies Respiratoires Actualit?s 2:5, pages 462-466.
Crossref
Crossref
Daisy JA Janssen, Martijn A Spruit, Carsten Leue, Candy Gijsen, Henry Hameleers, Jos MGA Schols & Emiel FM Wouters. (2010) Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation. Chronic Respiratory Disease 7:3, pages 147-157.
Crossref
Crossref
Marc B. Feinstein, Paul Krebs, Elliot J. Coups, Bernard J. Park, Richard M. Steingart, Jack Burkhalter, Amy Logue & Jamie S. Ostroff. (2010) Current Dyspnea Among Long-Term Survivors of Early-Stage Non-small Cell Lung Cancer. Journal of Thoracic Oncology 5:8, pages 1221-1226.
Crossref
Crossref
Salahaddin Mahmudi‐Azer. 2010. Evidence‐Based Geriatric Medicine. Evidence‐Based Geriatric Medicine
43
57
.
Lauren Rayner, Annabel Price, Alison Evans, Koravangattu Valsraj, Irene J Higginson & Matthew Hotopf. (2010) Antidepressants for depression in physically ill people. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Winfried Rief, Yvonne Nestoriuc, Anna von Lilienfeld-Toal, Imis Dogan, Franziska Schreiber, Stefan G. Hofmann, Arthur J. Barsky & Jerry Avorn. (2009) Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials. Drug Safety 32:11, pages 1041-1056.
Crossref
Crossref
Shoab A. Nazir & Marcia L. Erbland. (2009) Chronic Obstructive Pulmonary Disease. Drugs & Aging 26:10, pages 813-831.
Crossref
Crossref
Khaled Al-shair, Rachel Dockry, Brendan Mallia-Milanes, Umme Kolsum, Dave Singh & J?rgen Vestbo. (2009) Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respiratory Medicine 103:10, pages 1572-1579.
Crossref
Crossref
Neil Jordan, Todd A. Lee, Marcia Valenstein, Paul A. Pirraglia & Kevin B. Weiss. (2009) Effect of Depression Care on Outcomes in COPD Patients With Depression. Chest 135:3, pages 626-632.
Crossref
Crossref
Heidi Putman-Casdorph & Susan McCrone. (2009) Chronic obstructive pulmonary disease, anxiety, and depression: State of the science. Heart & Lung 38:1, pages 34-47.
Crossref
Crossref
Hyun Jung ChinKwan Ho LeeChan Soh ParkChang Woo SonHi-young LeeSung Ken YuKyeong Cheol ShinJin Hong ChungJung Youp Kim. (2008) Prevalence and Risk Factors of Depression in Patients with Chronic Obstructive Pulmonary Disease. Tuberculosis and Respiratory Diseases 65:3, pages 191.
Crossref
Crossref
Ganesh Shanmugam, Sumit Bhutani, David A. Khan & E. Sherwood Brown. (2007) Psychiatric Considerations in Pulmonary Disease. Psychiatric Clinics of North America 30:4, pages 761-780.
Crossref
Crossref
Shoab A. Nazir, Mohammad M. Al-Hamed & Marcia L. Erbland. (2007) Chronic Obstructive Pulmonary Disease in the Older Patient. Clinics in Chest Medicine 28:4, pages 703-715.
Crossref
Crossref
Andrew C. Stone & Linda Nici. (2007) Other Systemic Manifestations of Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine 28:3, pages 553-557.
Crossref
Crossref
Rachel Norwood. (2006) Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Current Opinion in Pulmonary Medicine 12:2, pages 113-117.
Crossref
Crossref